| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Sep 21, 2018 | Sep 25, 2018 | TITAN PHARMACEUTICALS INC | Director | Buy | 95.0 | +200,000 | 200.00% | ✗ | $50K |
| May 3, 2017 | May 5, 2017 | CURIS INC | Director | Sell | 28.8 | -76,276 | -7.58% | ✓ | $155.4K |
| May 3, 2017 | May 5, 2017 | CURIS INC | Director | Sell | 28.8 | -76,276 | -7.58% | ✓ | $155.4K |
| Apr 28, 2017 | May 2, 2017 | CURIS INC | Director | Sell | 7.5 | -116,708 | -48.03% | ✓ | $278K |
| Apr 20, 2017 | Apr 27, 2017 | CURIS INC | Director | Sell | 26.3 | -110,322 | -8.00% | ✓ | $285.7K |
| Apr 25, 2017 | Apr 27, 2017 | CURIS INC | Director | Sell | 22.5 | -146,694 | -11.56% | ✓ | $383K |
| Apr 20, 2017 | Apr 24, 2017 | CURIS INC | Director | Sell | 26.3 | -110,322 | -8.00% | ✓ | $285.7K |
| May 31, 2016 | May 31, 2016 | TITAN PHARMACEUTICALS INC | Director | Buy | 95.0 | +20,000 | 25.00% | ✗ | $140.6K |
| Jan 13, 2016 | Jan 14, 2016 | TITAN PHARMACEUTICALS INC | Director | Buy | 95.0 | +16,363 | 25.71% | ✗ | $51.7K |
| Jun 15, 2012 | Jun 19, 2012 | CURIS INC | Director | Sell | 17.5 | -300,000 | -17.54% | ✗ | $1.4M |
| Mar 31, 2011 | Apr 1, 2011 | CURIS INC | Director | Sell | 22.5 | -25,000 | -1.69% | ✗ | $81.3K |
| Mar 29, 2011 | Mar 31, 2011 | CURIS INC | Director | Sell | 22.5 | -50,000 | -3.27% | ✗ | $164K |
| Aug 6, 2008 | Aug 8, 2008 | CURIS INC | Director | Buy | 87.5 | +50,000 | 4.52% | ✗ | $78.2K |
| Aug 6, 2008 | Aug 8, 2008 | CURIS INC | Director | Sell | 22.5 | -50,000 | -4.15% | ✗ | $78.2K |
| Jun 6, 2008 | Jun 10, 2008 | CURIS INC | Director | Sell | 22.5 | -50,000 | -4.33% | ✗ | $71.2K |
| May 19, 2005 | May 23, 2005 | CURIS INC | Director | Sell | 52.5 | -522 | -0.05% | ✗ | $2.1K |
| May 17, 2005 | May 19, 2005 | CURIS INC | Director | Sell | 20.0 | -100,000 | -9.21% | ✗ | $401.2K |
| Nov 30, 2004 | Dec 2, 2004 | CURIS INC | Director | Buy | 87.5 | +29,075 | 2.75% | ✗ | $248.1K |